Direct fibrin injection to promote new collateral growth in hind limb ischemia in a rabbit model

Journal of Cardiac Surgery

Volumn 17, Issue 6, 2002, Pages 502-511

  Chekanov, Valeri S ^a,d   Rayel, Ramon ^a   Nikolaychik, Victor ^a   Kipshidze, Nicholas ^b   Baibekov, Iskander ^c   Karakozov, Paul ^c   Bajwa, Tanvir ^a   Akhtar, Masood ^a  

^a AURORA SINAI MEDICAL CENTER   (United States)

^b Lenox Hill Heart/Vascular Institute   (United States)

^c Vosit Vakhidov Sci Ctr of Surgery   (Uzbekistan)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; FIBRINOGEN; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFICACY; DRUG MEGADOSE; FEMORAL ARTERY; HINDLIMB; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; LIMB ISCHEMIA; LOW DRUG DOSE; NONHUMAN; POSTOPERATIVE PERIOD; RABBIT; TIBIAL ARTERY; ARTERY DILATATION; CORONARY ARTERY BYPASS GRAFT; GENE THERAPY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; NOTE; QUALITY OF LIFE; RESTENOSIS; SURVIVAL;

ANIMALS; BLOOD PRESSURE; CAPILLARIES; COLLATERAL CIRCULATION; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; FIBRIN; HINDLIMB; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAMUSCULAR; ISCHEMIA; LIGATION; MALE; MUSCLE, SKELETAL; NECROSIS; PAIN; RABBITS; TREATMENT OUTCOME;

EID: 85062126336     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8191.2002.01006.x     Document Type: Article

References (55)

1. European Working Group on Critical Leg Ischemia. Second European Consensus Document on Chronic Leg Ischemia. Circ 1991;84:IV1-IV26.
2. Most RS, Sinnock P. The epidemiology of lower extremity amputation in diabetic individuals. Diabetic Care 1983;6:87-91.
3. Ito WD, Arras M, Scholz D, et al. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 1997;42:H1255-H1265.
4. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-764.
5. Polverini PJ, Corran RS, Gimbrone MA, et al. Activated macrophages induce vascular proliferation. Nature 1997;269:804-806.
6. Terai M, Yasukawa K, Narumoto S, et al. Vascular endothelial factor in acute Kawasaki disease. Am J Card 1999;83:337-339.
7. Hirise S, Hamashima Y. Morphological observation on the vasculitis in the mucocutaneous lymph node syndrome. Eur J Pediatr 1978;129:17-27.
8. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Eur J Pediatr 1978;61:100-107.
9. Yamakawa R, Ishii M, Sugimura T, et al. Coronary endothelial dysfunction after Kawasaki disease: Evaluation by intracoronary injection of acetylcholine. J Am Coll Card 1998;31:1074-1080.
10. Mack C, Patel S, Schwarz E, et al. Biologic bypass with use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998;115:168-177.
11. Chekanov V, Nikolaychik V, Rieder MA, et al. Partial cardiac assistance begun immediately after latissimus dorsi muscle mobilization and cardiomyoplasty. Basic Appl Myol 1998;8:27-34.
12. Chekanov VS, Rieder MA, Tchekanov GV, et al. Comparison of different regimens of electrical stimulation applied to nonmobilized and newly mobilized latissimus dorsi muscle. J Cardiac Surg 1997;12:343-353.
13. Chekanov VS, Nikolaychik VV, Tchekanov GV. The use of biological glue for better adhesions between the skeletal muscle flap and the myocardium, and for increasing capillary ingrowth. J Thorac Cardiovasc Surg 1996;111:678-680.
14. Chekanov VS, Tchekanov GV, Rieder MA, et al. Biological glue increased ingrowth after cardiomyoplasty in an ischemic cardiomyoplasty model. ASAIO J 1996;42:M480-M487.
15. Chekanov V, Nikolaychik V, Rieder M, et al. Autologous biological glue and aprotinin prevent ischemia in latissimus dorsi muscle after mobilization. Basic Appl Myol 1998;8:211-219.
16. Chekanov VS, Nikolaychik V, Keelan MH, et al. Fibrin meshwork of angiogenic matrix for therapeutic angiogenesis. Circ 1998;98:456. Abstract.
17. Lal P, Sahoto H, Nikolaychik V, et al. Therapeutic angiogenesis in patients with advanced coronary artery disease. Circ 1998;98:352-353. Abstract.
18. Kipshidze NN, Chekanov V, Kappes S, et al. Therapeutic angiogenesis for critical limb ischemia to limit or avoid amputation. J Invasive Cardiol 1999;11:25-28.
19. Kabuto M, Kabuto T, Kobayashi H, et al. Experimental study of intraoperative local chemotherapy with fibrin glue containing nitrosourea for malignant gliomas. Surg Neurol 1995;44:151-157.
20. Lasa C Jr, Hollinger J, Drohan W, et al. Delivery of demineralized bone powder by fibrin sealant. Plast Reconstr Surg 1995;96:1409-1418.
21. Pu QL, Arekatz Z, Brassard R, et al. A demonstration of significantly enhanced neovascularization by angiogenic stimulation in the ischemic limb. Surg Forum 1992;43:368.
22. Balfour R, Berman J, Garb J, et al. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic FGF. J Vasc Surg 1992;16:181-191.
23. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994;93:662-670.
24. Morishita R, Nakamuro S, Hayashi S, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 1999;73:1379-1384.
25. Tyrrell MR, Wolfe JU. Critical leg ischemia: An appraisal of clinical definitions. Joint Vascular Res Group Br J Surg 1993;80:177-180.
26. Dawson I, Keller BP, Brand R, et al. Late outcomes of limb loss after failed intrainguinal bypass. J Vasc Surg 1995;21:613-622.
27. Skinner JA, Cohen AT. Augmentation for premature peripheral atherosclerosis: Do young patients do better? Lancet 1996;348:1396.
28. Enecoth M, Persson BM. Amputation for occlusive arterial disease: A prospective multicenter study of 177 amputees. Int Orthop 1992;16:383-387.
29. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infracted myocardium by angiogenic action of basic FGF. Science 1992;257:1401-1404.
30. Isner J, Walsh K, Symes J, et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circ 1995;91:2687-2692.
31. Baumgartner J, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circ 1995;91:2687-2692.
32. Laham R, Leimbach M, Chronos N, et al. Intracoronary administration of recombinant FGF-2 in patients with severe coronary artery disease. J Am Coll Card 1999;33:383A.
33. Laham R, Selke F, Edelman E, et al. Local perivascular delivery of basic FGF in patients undergoing coronary bypass surgery: Results of a phase I randomized, double blind, placebo controlled trial. Circ 1999;100:1865-1871.
34. Hershey JC, Baskin EP, Glass JD, et al. Revascularization in rabbit hind limb: Dissociation between capillary sprouting and ateriogenesis. Cardiovas Res 2001;49:618-625.
35. Cooke JP, Bhatnager R, Szuba A, et al. Fibroblast growth factor as therapy for critical limb ischemia: case report. Vasc Med 1999;4:89-91.
36. Chawla PS, Keelan MN, Kipshidze N. Angiogenesis for treatment of vascular diseases. Int Angiol 1999;18:185-192.
37. Baffour R, Garb JL, Kaufman J, et al. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res 2000;93:219-229.
38. Godwak LH, Poliakova L, Li Z, et al. Induction of angiogenesis by cationic lipid mediated VEGF165 gene transfer in the rabbit ischemic hind limb model. J Vasc Surg 2000;32:343-352.
39. Lazarous DF, Unger EF, Epstein SE, et al. Basic fibroblast growth factor in patients with intermittent claudication: Results of a phase I trial. J Am Coll Card 2000;36:1239-1244.
40. Marti HH, Risau W. Angiogenesis in ischemic disease. Thromb Haemost 1999;82:44-52.
41. Bauters C, Ashura T, Zheng L, et al. Site-specific therapeutic angiogenesis after sytemic administration of vascular endothelial growth factor. J Vasc Surg 1995;21:314-325.
42. Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circ 1996;94:3281-3290.
43. Banai S, Jaklitsch M, Casscells W, et al. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res 1991;69:76-85.
44. Rivard A, Isner M. Angiogenesis and vasculogenesis in treatment of cardiovascular disease. Mol Med 1998;4:429-440.
45. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934.
46. Sahni A, Odrtjin T, Francis C. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998;273:13-19.
47. Pandit AS, Feldman DS, Caulfield J, et al. Stimulation of angiogenesis by FGF-1 delivered through a modified fibrin scaffold. Growth Factors 1998;15:113-123.
48. Weatherford D, Sackman J, Reddick T, et al. Vascular endothelial growth factor and heparin in a biological glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition. Surgery 1996;120:433-439.
49. Fasel R, Schumacher B, Schlandraff K. Experiments on a modified fibrin glue to induce site-directed angiogenesis from the aorta to the heart. J Thorac Cardiovasc Surg 1994;: 107.
50. Pasykm S, Schaper W, Schaper J, et al. DNA synthesis in coronary collaterals after coronary occlusion in the conscious dog. Am J Physiol 1983;242:H1031-H1037.
51. Kumar S, West D, Schahabuddin S, et al. Angiogenesis factor from human myocardium infarcts. Lancet 1983;13:364-368.
52. Chalupowicz D, Chowdury Z, Bach T, et al. Fibrin II induces endothelial cell capillary tube formation. J Cell Biol 1995;130:207-215.
53. Nehls V, Dronckhahn D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvascular Res 1995;50:311-322.
54. Ito WD, Arras M, Winkler B, et al. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Cinc Res 1997;80:829-837.
55. Shireman PK, Greisler HP. Mitogenicity and release of vascular endothelial growth factor with and without heparin from fibrin glue. J Vasc Surg 2000;31:936-943.